Rahim Ullah

Dr. Rahim Ullah

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KCKuangqi Chen
Kuangqi Chen
YLYanqing Li
Yanqing Li
XZXuhong Zhang
Xuhong Zhang
RURahim Ullah
Rahim Ullah
JTJianping Tong
Jianping Tong
YSYe Shen
Ye Shen
Phosphatidylinositol 3 kinase (PI3K)/AKT (also called protein kinase B, PKB) signalling regulates various cellular processes, such as apoptosis, cell proliferation, the cell cycle, protein synthesis, glucose metabolism, and telomere activity. Corneal epithelial cells (CECs) are the outermost cells of the cornea; they maintain good optical performance and act as a physical and immune barrier. Various growth factors, including epidermal growth factor receptor (EGFR) ligands, insulin-like growth factor 1 (IGF1), neurokinin 1 (NK-1), and insulin activate the PI3K/AKT signalling pathway by binding their receptors and promote antiapoptotic, anti-inflammatory, proliferative, and migratory functions and wound healing in the corneal epithelium (CE). Reactive oxygen species (ROS) regulate apoptosis and inflammation in CECs in a concentration-dependent manner. Extreme environments induce excess ROS accumulation, inhibit PI3K/AKT, and cause apoptosis and inflammation in CECs. However, at low or moderate levels, ROS activate PI3K/AKT signalling, inhibiting apoptosis and stimulating proliferation of healthy CECs. Diabetes-associated hyperglycaemia directly inhibit PI3K/AKT signalling by increasing ROS and endoplasmic reticulum (ER) stress levels or suppressing the expression of growth factors receptors and cause diabetic keratopathy (DK) in CECs. Similarly, hyperosmolarity and ROS accumulation suppress PI3K/AKT signalling in dry eye disease (DED). However, significant overactivation of the PI3K/AKT signalling pathway, which mediates inflammation in CECs, is observed in both infectious and noninfectious keratitis. Overall, upon activation by growth factors and NK-1, PI3K/AKT signalling promotes the proliferation, migration, and anti-apoptosis of CECs, and these processes can be regulated by ROS in a concentration-dependent manner. Moreover, PI3K/AKT signalling pathway is inhibited in CECs from individuals with DK and DED, but is overactivated by keratitis.

23 June 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SZShumin Zhan
Shumin Zhan
KHKe Huang
Ke Huang
WWWei Wu
Wei Wu
DZDanni Zhang
Danni Zhang
ALAna Liu
Ana Liu
JFJunfen Fu
Junfen Fu
Context: Although gonadotropin-releasing hormone stimulation test (GnRHST) is the gold standard in diagnosing central precocious puberty (CPP), it is invasive, expensive, and time-consuming, requiring multiple blood samples to measure gonadotropin levels.Objective: We evaluated whether urinary hormones could be potential biomarkers for prepuberty or postpuberty, aiming to simplify the current diagnosis and prognosis procedure.Methods: We performed a cross-sectional study of a total of 355 girls with CPP in National Clinical Research Center for Child Health in China, including 258 girls with positive and 97 girls with negative results from GnRHST. Twenty patients received GnRH analogue (GnRHa) treatment and completed a 6-month follow up. We measured luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, progesterone, testosterone, and human chorionic gonadotropin in the first morning voided urine samples.Results: Their urinary LH levels and the ratios of LH to FSH increased significantly with the advancement in Tanner stages. uLH levels were positively associated with basal and peak LH levels in the serum after GnRH stimulation. A cutoff value of 1.74 IU/L for uLH reached a sensitivity of 69.4% and a specificity of 75.3% in predicting a positive GnRHST result. For the combined threshold (uLH ≥ 1.74 + uLH-to-uFSH ratio > 0.4), the specificity reached 86.6%. After 3 months of GnRHa therapy, the uLH and uFSH levels decreased accordingly.Conclusion: uLH could be a reliable biomarker for initial CPP diagnosis and screening; uLH could also be an effective marker for evaluating the efficacy of clinical treatment.

4 October 2024 in Nutrition & Diabetes
Verified
Journal Article
Open access
PDF file
RURahim Ullah
Rahim Ullah
CXChuqing Xue
Chuqing Xue
SWSenjie Wang
Senjie Wang
ZQZhewen Qin
Zhewen Qin
NRNaveed Rauf
Naveed Rauf
JFJunfen Fu
Junfen Fu
Background/Objectives Childhood obesity, particularly in girls, is linked to early puberty onset, heightening risks for adult-onset diseases. Addressing childhood obesity and precocious puberty is vital to mitigate societal burdens. Despite existing costly and invasive medical interventions, introducing lifestyle-based alternatives is essential. Our study investigates alternate-day fasting’s (ADF) impact on pubertal development in normal-weight and high-fat diet (HFD)-induced obese female mice. Methods Four groups of female mice were utilized, with dams initially fed control chow during and before pregnancy. Post-parturition, two groups continued on control chow, while two switched to an HFD. Offspring diets mirrored maternal exposure. One control and one HFD group were subjected to ADF. Morphometry and hormone analyses at various time points were performed. Results Our findings demonstrate that ADF in normal-weight mice led to reduced body length, weight, uterine, and ovarian weights, accompanied by delayed puberty and lower levels of sex hormones and growth hormone (GH). Remarkably, GH treatment effectively prevented ADF-induced growth reduction but did not prevent delayed puberty. Conversely, an HFD increased body length, induced obesity and precocious puberty, and altered sex hormones and leptin levels, which were counteracted by ADF regimen. Our data indicate ADF’s potential in managing childhood obesity and precocious puberty. Conclusions ADF reduced GH and sex hormone levels, contributing to reduced growth and delayed puberty, respectively. Therefore, parents of normal-weight children should be cautious about prolonged overnight fasting. ADF prevented HFD-induced obesity and precocious puberty, offering an alternative to medical approaches; nevertheless, further studies are needed for translation into clinical practice.

1 January 2026 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
SWSenjie Wang
Senjie Wang
WZWei Zhang
Wei Zhang
ZQZhewen Qin
Zhewen Qin
XZXuelian Zhou
Xuelian Zhou
CXChuqing Xue
Chuqing Xue
RURahim Ullah
Rahim Ullah
Background: Sarcopenic obesity (SO) is well‐characterized in older adults, but its impact on muscle development in children remains poorly understood. This study investigated the effects of childhood obesity on musculoskeletal health and the underlying mechanisms. Methods: We enrolled 1447 children (31.4% girls; median age 11.10 years, IQR 9.39–12.50) for body composition assessment via dual‐energy X‐ray absorptiometry (DXA) and a separate cohort of 349 children (33.2% girls; median age 11.13 years, IQR 9.73–12.80) for grip strength measurement. A juvenile mouse model of high‐fat diet (HFD)‐induced obesity was established and compared to an adult‐onset model. Molecular pathways were examined via RNA sequencing and RT‐qPCR. Interventions included dietary reversal and vitamin C supplementation. Results: In children, the appendicular skeletal muscle mass ratio (ASMR) Z‐score was inversely correlated with BMI‐Z score ( ρ = −0.369, p < 0.001) and body fat percentage ( ρ = −0.668, p < 0.001). According to weight‐specific reference criteria, most of children with obesity exhibited low grip strength (below the 25th percentile). In mice, 4 weeks of HFD feeding in juveniles, but not adults, significantly reduced muscle mass (−6%, p < 0.05), muscle fibre diameter (−8%, p < 0.001), grip strength (−14%, p < 0.01) and rotarod performance (−29%, p < 0.05). RNA sequence and RT‐qPCR revealed that HFD suppressed myogenic regulatory factors (e.g., Myod , Myog ) and promoted adipogenic pathways specifically in juveniles. In stark contrast, adult mice showed no such impairments after 4 weeks of HFD. The muscle deficits caused by juvenile obesity were not resolved but persisted even after subsequent dietary weight loss. Vitamin C supplementation effectively mitigated HFD‐induced impairments, increasing muscle fibre diameter (~15%, p < 0.001, vs. HFD), grip strength (~10%, p < 0.001, vs. HFD) and expression of key myogenic genes (e.g., Myod , Myog , all p < 0.05). Conclusions: Childhood obesity critically impairs muscle development during the juvenile growth period, driven by transcriptomic reprogramming that suppresses myogenesis. These deficits are persistent and not reversed by weight loss alone. Vitamin C supplementation presents a potential therapeutic strategy to protect muscle health in children with obesity. The juvenile mouse model established herein provides a novel tool for future research into childhood SO.